+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BPLPHARMA BPLPHARMA

Bharat Parenterals Share Price

₹1,343.25 -17.35 (-1.28%)
52.60% Gain from 52W Low

14 Aug, 2026 4:01 PM (IST)

Bharat Parenterals live price: ₹1,343.25. It opened at ₹1,361 vs previous close ₹1,361; intraday high/low: ₹1,419/₹1,334. The 50 & 200 DMA stand at ₹1,384.60/₹1,273.20.

Bharat Parenterals Performance

  • Today's Low
  • ₹1,334
  • Today's High
  • ₹1,419
  • 52 Week Low
  • ₹880
  • 52 Week High
  • ₹1,560
  • Open Price₹1,361
  • Previous Close₹1,361
  • Volume6,232
  • 50 DMA₹1,384.60
  • 100 DMA₹1,324.40
  • 200 DMA₹1,273.20

Bharat Parenterals Chart

Investment Returns

  • Over 1 Month -5.22%
  • Over 3 Month + 8.32%
  • Over 6 Month + 28.61%
  • Over 1 Year -5.03%

Smart Investing Starts Here Start SIP with Bharat Parenterals for Steady Growth!

Invest Now

Bharat Parenterals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -60.1
  • PEG Ratio
  • -31.8
  • Market Cap Cr
  • 926
  • P/B Ratio
  • 2.9
  • Average True Range
  • 63
  • EPS
  • -22.3
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -8.8
  • RSI
  • 40.15
  • MFI
  • 50.89

Latest Stock News Updates

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd, a Wholly Owned Subsidiary Company of Bharat Parenterals Limited

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR), Regulations, 2015.

Bharat Parenterals Financials

Bharat Parenterals Technicals

EMA & SMA

Current Price
₹1,343.25
-17.35 (-1.28%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹1,411.10
  • 50 Day
  • ₹1,384.60
  • 100 Day
  • ₹1,324.40
  • 200 Day
  • ₹1,273.20

Resistance and Support

1365.25 Pivot Speed
  • R3 1,486.60
  • R2 1,452.80
  • R1 1,401.10
  • S1 1,315.60
  • S2 1,281.80
  • S3 1,230.10

Bharat Parenterals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-05 Quarterly Results & A.G.M.
2026-05-18 Audited Results & Final Dividend
2026-01-30 Quarterly Results
2025-11-12 Quarterly Results
2025-07-28 Quarterly Results & A.G.M.
Date Purpose Remarks
2025-09-19 FINAL Rs.1.00 per share(10%)Final Dividend
2024-06-25 FINAL Rs.1.00 per share(10%)Final Dividend
2023-09-25 FINAL Rs.0.75 per share(7.5%)Final Dividend
View Bharat Parenterals Dividend History Arrow

Bharat Parenterals Shareholding Pattern

67.2%
31.31%
1.38%
0.11%

About Bharat Parenterals

Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India. View More
  • NSE Symbol
  • BPLPHARMA
  • BSE Symbol
  • 541096
  • ISIN
  • INE365Y01019

Similar Stocks to Bharat Parenterals

Bharat Parenterals FAQs

Bharat Parenterals share price is ₹1,343 As on 15 August, 2026 | 06:18

The Market Cap of Bharat Parenterals is ₹925.8 Cr As on 15 August, 2026 | 06:18

The P/E ratio of Bharat Parenterals is -60.1 As on 15 August, 2026 | 06:18

The PB ratio of Bharat Parenterals is 2.9 As on 15 August, 2026 | 06:18

The 52 week High & Low of Bharat Parenterals is ₹1559.9/₹880.2 respectively As on 15 August, 2026 | 06:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23